Head to Head Contrast: Drägerwerk AG & Co. KGaA (OTCMKTS:DGWPF) & ReWalk Robotics (NASDAQ:RWLK)

Drägerwerk AG & Co. KGaA (OTCMKTS:DGWPFGet Free Report) and ReWalk Robotics (NASDAQ:RWLKGet Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Drägerwerk AG & Co. KGaA and ReWalk Robotics, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drägerwerk AG & Co. KGaA 0 0 0 0 N/A
ReWalk Robotics 0 0 1 0 3.00

ReWalk Robotics has a consensus price target of $3.00, indicating a potential upside of ∞. Given ReWalk Robotics’ higher probable upside, analysts clearly believe ReWalk Robotics is more favorable than Drägerwerk AG & Co. KGaA.

Valuation and Earnings

This table compares Drägerwerk AG & Co. KGaA and ReWalk Robotics’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Drägerwerk AG & Co. KGaA N/A N/A N/A $5.51 9.26
ReWalk Robotics $5.51 million 0.00 -$19.57 million ($0.37) N/A

Drägerwerk AG & Co. KGaA has higher earnings, but lower revenue than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than Drägerwerk AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.


This table compares Drägerwerk AG & Co. KGaA and ReWalk Robotics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Drägerwerk AG & Co. KGaA N/A N/A N/A
ReWalk Robotics -238.35% -29.00% -25.27%

Institutional and Insider Ownership

13.9% of Drägerwerk AG & Co. KGaA shares are held by institutional investors. Comparatively, 3.6% of ReWalk Robotics shares are held by institutional investors. 2.1% of ReWalk Robotics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.


Drägerwerk AG & Co. KGaA beats ReWalk Robotics on 6 of the 10 factors compared between the two stocks.

About Drägerwerk AG & Co. KGaA

(Get Free Report)

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.

About ReWalk Robotics

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.